EVMN

Evommune
$6.31
+$1.15 (+22.29%)Oct 28, 2026
1.5PoorMoatMint rating

MoatMint rates Evommune (EVMN) 1.5 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.9 out of 10.

Return-68.8%5YRange $5.10 - $31.57
$34.7$23.8$12.9$1.9Nov 25May 26Oct 26

Key metrics

The numbers that frame EVMN today
Market cap
$229.00M
Gross margin
100%
EV / Sales
17.6
ROIC
-53.2%
Div yield
0%
Debt / equity
0.0

EVMN stock rating

How EVMN scores on quality, value, growth, momentum and financial health
1.5out of 10
Low overallNeutral business, expensive price
Quality0.9
Growth-
Momentum-
Value0.8
Financial Health2.0

Growth

Revenue and earnings trend for EVMN
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about EVMN
Is Evommune a good buy?
No. Evommune has poor quality. We think Evommune is selling at a very high price.
What is the market capitalization of EVMN?
Evommune's market capitalization is $229.00M.
Does EVMN stock pay dividends?
Evommune does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EVMN?
Evommune's Debt / Equity ratio is 0.03.